Acron (MOEX:AKRN)

SpringWorks Therapeutics Ratios and Metrics

Market cap in millions RUB. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019
Period Ending	Jul 7, 2022	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	674,935	667,484	673,638	674,935	221,062	186,240
Market Cap Growth	-1.04%	-0.91%	-0.19%	205.31%	18.70%	0.61%
Enterprise Value	777,782	780,918	737,166	777,782	363,812	287,479
Last Close Price	18362.00	18362.00	18362.00	18362.00	5465.45	4102.24
PE Ratio	17.38	21.93	18.86	7.46	66.79	7.69
Forward PE	-	7.10	7.10	7.10	10.73	7.80
PS Ratio	3.16	3.37	3.75	2.62	1.84	1.62
PB Ratio	3.02	3.19	2.92	3.46	3.21	2.27
P/TBV Ratio	3.14	3.30	3.31	4.01	5.18	3.05
P/FCF Ratio	-	-	39.39	18.76	26.82	20.14
P/OCF Ratio	-	27.71	10.80	10.31	8.44	6.59
PEG Ratio	-	0.78	0.78	0.78	0.78	0.78
EV/Sales Ratio	3.64	3.94	4.11	3.02	3.04	2.50
EV/EBITDA Ratio	10.57	12.86	10.72	5.71	10.46	8.15
EV/EBIT Ratio	12.90	16.39	13.11	6.26	15.68	11.78
EV/FCF Ratio	-70.01	-	43.10	21.61	44.13	31.09
Debt / Equity Ratio	0.65	0.83	0.46	0.41	1.71	1.09
Debt / EBITDA Ratio	1.98	2.87	1.54	0.58	3.34	2.49
Debt / FCF Ratio	-	-	6.19	2.21	14.29	9.64
Asset Turnover	0.54	0.48	0.51	-	0.57	0.59
Inventory Turnover	3.12	2.78	2.81	-	3.69	3.61
Quick Ratio	0.89	0.80	1.14	2.10	0.43	0.59
Current Ratio	1.29	1.13	1.59	2.97	0.80	1.27
Return on Equity (ROE)	17.75%	13.87%	16.85%	-	5.09%	30.96%
Return on Assets (ROA)	9.53%	7.20%	9.92%	-	6.90%	7.88%
Return on Capital (ROIC)	10.93%	8.27%	11.50%	-	8.11%	9.14%
Return on Capital Employed (ROCE)	18.80%	15.70%	19.20%	44.30%	14.40%	14.60%
Earnings Yield	5.70%	4.56%	5.30%	13.40%	1.50%	13.00%
FCF Yield	-1.65%	-3.36%	2.54%	5.33%	3.73%	4.97%
Dividend Yield	0.33%	2.91%	2.33%	-	0.55%	12.99%
Payout Ratio	26.82%	33.89%	-	6.35%	496.92%	59.10%
Buyback Yield / Dilution	2.38%	0.78%	0.17%	2.40%	3.61%	0.69%
Total Shareholder Return	2.70%	3.69%	2.50%	2.40%	4.16%	13.68%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.